1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Asciminib single agent: new trials by email Literature Review of Asciminib single agent trials Research Report on Asciminib single agent
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP Asciminib single agent - Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, Philadelphia Chromosome Positive | Phase 2 | Recruiting | Novartis Pharmaceuticals | 50 | 2026-04-28 | 2026-10-15 |
Bronchiolitis Obliterans Syndrome (1) · Leukemia (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1)
Australia (1) · Brazil (1) · Canada (1) · China (1) · France (1) · Germany (1) · Hungary (1) · Italy (1) · Japan (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1) · Thailand (1) · United States (1)
2025 (1)